Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Obesity × Cyproterone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 1 Overweight 1 Obesity 1

Interventions

Metformin 9 Liraglutide 3 Exercise 3 Tirzepatide 2 Docosahexaenoic Acids 2 Diet 2 sibutramine 1 semaglutide 1 Ursodeoxycholic Acid 1 Topiramate 1 Solutions 1 Propofol 1 Nutrition Therapy 1 Nutrition Assessment 1 Injections 1 Exenatide 1 Doxorubicin 1 Cyproterone 1 Cyclophosphamide 1 Caloric Restriction 1 (2-(1R)-1-cyclopropyl)ethyl-6-isopropyl-phenol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03151005 2023-12-04

The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS

Xinqiao Hospital of Chongqing

Phase 4 Completed

70 enrolled 11 charts

Obesity, Polycystic Ovary Syndrome, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡